Russian Federation

Services, news and resources from Russian Federation

Access to medicines & diagnostics

Russia struggling with adequate access to hepatitis C drugs

Pharma Letter / 25 October 2021
Hepatitis D

Myrcludex B plus tenofovir suppresses hepatitis delta

Liz Highleyman / 30 April 2018

An experimental drug that blocks the entry of hepatitis B virus (HBV) and hepatitis delta virus (HDV) into liver cells suppressed HBV and HDV levels and led to improvement in ...
Treatment outcomes

Real-world studies show 8-week sofosbuvir/ledipasvir course just as effective as 12-week course for genotype 1 patients without cirrhosis

Keith Alcorn / 02 December 2016

An 8-week course of treatment with sofosbuvir/ledipasvir is just as effective as a 12-week course of treatment in people without cirrhosis, including those with HIV/hepatitis C virus (HCV) co-infection, and could significantly reduce ...
Access to medicines & diagnostics

Buyers clubs for cheaper drugs help fight hepatitis and HIV

Reuters / 07 November 2016
Access to medicines & diagnostics

Generic hepatitis C drugs purchased online achieve high cure rates

Keith Alcorn / 27 October 2016

Use of generic versions of direct-acting antivirals resulted in very high cure rates for people who obtained the products through three buyers’ clubs, indicating that the generic products are effective, according to three ...